Learn / AVIR
NASDAQ: AVIR
Atea Pharmaceuticals (AVIR) stock, explained like you're 5
Atea Pharmaceuticals trades on the Nasdaq under the ticker AVIR. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 413 million dollars.
- Ticker
- AVIR
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 413 million dollars
Is Atea Pharmaceuticals a small, medium or large cap company?
No. Atea Pharmaceuticals is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 413 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Atea Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves AVIR stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- AVIR Dec 2027 5.000 call (AVIR271217C00005000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
- A stake in Atea Pharmaceuticals (AVIR) is no longer held to influence control. (Stock Titan)
- AVIR Forecast Price Target Prediction for 2027 (TradingView)
- ATEA PHARMACEUTICALS ($AVIR) Releases Q2 2026 Earnings | AVIR Stock News (Quiver Quantitative)
- We Think Atea Pharmaceuticals (NASDAQ:AVIR) Needs To Drive Business Growth Carefully (Simply Wall Street)
Follow AVIR in your daily brief
Each trading day at 5 PM ET we post what happened to Atea Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow AVIR
Questions about Atea Pharmaceuticals stock
What does Atea Pharmaceuticals do?
Atea Pharmaceuticals trades on the Nasdaq under the ticker AVIR. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 413 million dollars.
What is the ticker symbol for Atea Pharmaceuticals?
Atea Pharmaceuticals trades under the ticker AVIR on the Nasdaq.
What is Atea Pharmaceuticals's market cap?
Atea Pharmaceuticals is a small cap stock with a market cap of about 413 million dollars.
How does Atea Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves AVIR stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow AVIR stock every day?
Add AVIR to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.